Blue Trust Inc’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-97
Closed -$7.98K 2743
2024
Q3
$7.98K Buy
+97
New +$8.4K ﹤0.01% 2273
2023
Q4
Sell
-110
Closed -$7K 2612
2023
Q3
$7K Hold
110
﹤0.01% 1534
2023
Q2
$6K Hold
110
﹤0.01% 1471
2023
Q1
$5K Hold
110
﹤0.01% 1788
2022
Q4
$6K Buy
110
+55
+100% +$2.58K ﹤0.01% 1677
2022
Q3
$3K Hold
55
﹤0.01% 1695
2022
Q2
$3K Buy
+55
New +$2.46K ﹤0.01% 1576

Other funds holding LMAT

Blue Trust Inc's LMAT Position: Q4 2024 in Review

Blue Trust Inc sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 97 shares — an estimated $7.98K sold.

Blue Trust Inc first reported a position in LMAT in Q2 2022 and held it in 7 quarters. The position peaked at $7.98K in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Blue Trust Inc reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 97 LeMaitre Vascular shares in Q4 2024, an estimated $7.98K.
  • Blue Trust Inc first reported a position in LeMaitre Vascular in Q2 2022 and held it in 7 quarters.
  • Blue Trust Inc's LeMaitre Vascular position peaked at $7.98K in Q3 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.